7-氨基放线菌素D

更新时间：2024-01-02 18:54:25

7-氨基放线菌素D结构式	常用名	7-氨基放线菌素D	英文名	7-Aminoactinomycin D
	CAS号	7240-37-1	分子量	1270.432
	密度	1.4±0.1 g/cm3	沸点	1400.8±65.0 °C at 760 mmHg
	分子式	C₆₂H₈₇N₁₃O₁₆	熔点	N/A
	MSDS	中文版美版	闪点	801.0±34.3 °C
	符号	GHS06	信号词	Danger

7-氨基放线菌素D用途

7-Aminoactinomycin D 是一种荧光 DNA 染色剂。

中文名	7-氨基放线菌素D
英文名	7-aminoactinomycin D
英文别名	更多

描述	7-Aminoactinomycin D 是一种荧光 DNA 染色剂。
相关类别	信号通路 >> 其他 >> 其他染料试剂研究领域 >> 其他
参考文献	[1]. Wadkins RM, et al. Actinomycin D and 7-aminoactinomycin D binding to single-stranded DNA. Biochemistry. 1991 Oct 1;30(39):9469-78.

密度	1.4±0.1 g/cm3
沸点	1400.8±65.0 °C at 760 mmHg
分子式	C₆₂H₈₇N₁₃O₁₆
分子量	1270.432
闪点	801.0±34.3 °C
精确质量	1269.639404
PSA	386.00000
LogP	-5.02
外观性状	红色至暗紫色粉末
蒸汽压	0.0±0.3 mmHg at 25°C
折射率	1.664
储存条件	2-8°C
水溶解性	chloroform: 1 mg/mL, clear, red
计算化学	1.疏水参数计算参考值（XlogP）:3.1 2.氢键供体数量:6 3.氢键受体数量:19 4.可旋转化学键数量:8 5.互变异构体数量:1000 6.拓扑分子极性表面积382 7.重原子数量:91 8.表面电荷:0 9.复杂度:3070 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:10 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1

7-氨基放线菌素D毒性英文版

符号	GHS06
信号词	Danger
危害声明	H300
警示性声明	Missing Phrase - N15.00950417
个人防护装备	Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges
危害码 (欧洲)	T+: Very toxic;
风险声明 (欧洲)	R26/27/28;R36/37/38
安全声明 (欧洲)	26-28-36/37-45
危险品运输编码	UN 3462 6
WGK德国	3
RTECS号	AU1579000
包装等级	II
危险类别	6.1(a)

7-氨基放线菌素D上游产品 0
7-氨基放线菌素D下游产品 1
CAS号64604-59-7 2-amino-7-(benz...

Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation.

PLoS Genet. 10(11) , e1004741, (2014)

Aggregation of alpha-synuclein (ASYN) in Lewy bodies and Lewy neurites is the typical pathological hallmark of Parkinson's disease (PD) and other synucleinopathies. Furthermore, mutations in the gene ...

Ellipticine induces apoptosis in T-cell lymphoma via oxidative DNA damage.

Leuk. Lymphoma 56(3) , 739-47, (2015)

The tumor suppressor p53 is often mutated in human cancers. Restoring its antitumor activity has been shown to be a promising therapeutic approach for cancer treatment. Here we analyzed the activity a...

Nonbinding site-directed mutants of transferrin binding protein B exhibit enhanced immunogenicity and protective capabilities.

Infect. Immun. 83(3) , 1030-8, (2015)

Host-adapted Gram-negative bacterial pathogens from the Pasteurellaceae, Neisseriaceae, and Moraxellaceae families normally reside in the upper respiratory or genitourinary tracts of their hosts and r...

7-Aminodactinomycin

MFCD00077295

7AAD

3H-Phenoxazine-1,9-dicarboxamide, 2,7-diamino-N,N-bis[hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-4, 
6-dimethyl-3-oxo-

2,7-Diamino-N,N'-bis[(6S,9R,10S,13R,18aS)-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,11,14-pentaoxohexadecahydro-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide

7-Actinomycin C1

2,7-Diamino-N,N'-bis(6,13-diisopropyl-2,5,9-trimethyl-1,4,7,11,14-pentaoxohexadecahydro-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide

3H-Phenoxazine-1,9-dicarboxamide, 2,7-diamino-N,N-bis[(6S,9R,10S,13R,18aS)-hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyc 
lohexadecin-10-yl]-4,6-dimethyl-3-oxo-

7-amino-actinomycin-D

2,7-diamino-4,6-dimethyl-3-oxo-1-N,9-N-bis[7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide

7-amino-AMD

Actinomycin D,7-amino